Related stories
Sellas Life Sciences tumbles on $150 million stock sale at steep discount
Shares fell after the company’s $150 million stock sale was priced at a steep discount.
M impact | EQUITY | Nov 19, 2026, 11:52 AM UTC
PDD Holdings Shares Rise 8.7% Premarket After Q3 Results
M impact | EQUITY | Nov 19, 2026, 11:51 AM UTC
PDD Holdings' Q3 Revenue Flat Amid Transaction Services Weakness
PDD Holdings reported flat Q3 revenue, with weakness in transaction services.
M impact | EQUITY | Nov 19, 2026, 11:48 AM UTC
PDD Q3 2026 Earnings
Rev: 108.3B Yuan (est 115.21B Yuan) - Adj Operating Profit: 32.64B Yuan (est 27.85B Yuan) - Adj Earnings Per ADS: 21.04 Yuan (est 18.54 Yuan) - Transaction Services Rev: 48.52B Yua
H impact | EARNINGS | Nov 19, 2026, 11:42 AM UTC
Loblaw Q3 Revenue Slightly Misses Expectations as Food Retail Slows
Loblaw's third-quarter revenue slightly missed expectations amid a slowdown in food retail.
M impact | EQUITY | Nov 19, 2026, 11:39 AM UTC
CRH Receives $960.55 Million of Arcosa Notes in Cash Offers
CRH received tenders for $960.55 million of Arcosa notes in cash offers.
M impact | EQUITY | Nov 19, 2026, 11:38 AM UTC